Found: 7
Select item for more details and to access through your institution.
Safety and efficacy of filgotinib, lanraplenib and tirabrutinib in Sjögren's syndrome: a randomized, phase 2, double-blind, placebo-controlled study.
- Published in:
- Rheumatology, 2022, v. 61, n. 12, p. 4797, doi. 10.1093/rheumatology/keac167
- By:
- Publication type:
- Article
Urticaria mimickers in children.
- Published in:
- Dermatologic Therapy, 2013, v. 26, n. 6, p. 467, doi. 10.1111/dth.12103
- By:
- Publication type:
- Article
Skin and Mucosal Manifestations in NEMO Syndrome: A Case Series and Literature Review.
- Published in:
- Pediatric Dermatology, 2022, v. 39, n. 1, p. 84, doi. 10.1111/pde.14905
- By:
- Publication type:
- Article
Systemic immunosuppressive therapy for inflammatory skin diseases in children: Expert consensus‐based guidance for clinical decision‐making during the COVID‐19 pandemic.
- Published in:
- Pediatric Dermatology, 2020, v. 37, n. 3, p. 424, doi. 10.1111/pde.14202
- By:
- Publication type:
- Article
Signal transducer and activator of transcription 4 limits the development of adaptive regulatory T cells.
- Published in:
- Immunology, 2009, v. 127, n. 4, p. 587, doi. 10.1111/j.1365-2567.2008.03037.x
- By:
- Publication type:
- Article
Regulatory T cells in skin are uniquely poised to suppress profibrotic immune responses.
- Published in:
- Science Immunology, 2019, v. 4, n. 39, p. 1, doi. 10.1126/sciimmunol.aaw2910
- By:
- Publication type:
- Article
Evaluation of the potential for pharmacokinetic interaction between tirabrutinib and levonorgestrel/ethinyl estradiol in healthy female volunteers.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 6, p. 1492, doi. 10.1111/cts.13265
- By:
- Publication type:
- Article